Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis.

Robert J Nordyke Kevin J Appelbaum Mark A Berman

Published in: Journal of medical Internet research (2019)

The DTxs studied may provide substantial cost savings, in part by reducing the use of conventional medications. Clinical inertia may limit the full cost savings of DTxs.

Keyphrases

type diabetes
blood pressure
healthcare
public health
small molecule
cardiovascular disease
insulin resistance
metabolic syndrome
adipose tissue
risk assessment
climate change
social media
data analysis